• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估常见对接程序正确重现和评分 SARS-CoV-2 蛋白酶 Mpro 结合模式的能力。

Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro.

机构信息

Department of Chemistry and Institute for Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat-Gan 52900, Israel.

出版信息

J Chem Inf Model. 2021 Jun 28;61(6):2957-2966. doi: 10.1021/acs.jcim.1c00263. Epub 2021 May 28.

DOI:10.1021/acs.jcim.1c00263
PMID:34047191
Abstract

The coronavirus SARS-CoV-2 main protease, M, is conserved among coronaviruses with no human homolog and has therefore attracted significant attention as an enzyme drug target for COVID-19. The number of studies targeting M for in silico screening has grown rapidly, and it would be of great interest to know in advance how well docking methods can reproduce the correct ligand binding modes and rank these correctly. Clearly, current attempts at designing drugs targeting M with the aid of computational docking would benefit from a priori knowledge of the ability of docking programs to predict correct binding modes and score these correctly. In the current work, we tested the ability of several leading docking programs, namely, Glide, DOCK, AutoDock, AutoDock Vina, FRED, and EnzyDock, to correctly identify and score the binding mode of M ligands in 193 crystal structures. None of the codes were able to correctly identify the crystal structure binding mode (lowest energy pose with root-mean-square deviation < 2 Å) in more than 26% of the cases for noncovalently bound ligands (Glide: top performer), whereas for covalently bound ligands the top score was 45% (EnzyDock). These results suggest that one should perform in silico campaigns of M with care and that more comprehensive strategies including ligand free energy perturbation might be necessary in conjunction with virtual screening and docking.

摘要

冠状病毒 SARS-CoV-2 的主要蛋白酶 M 在冠状病毒中是保守的,没有人类同源物,因此作为 COVID-19 的酶药物靶点引起了极大的关注。针对 M 进行计算机筛选的研究数量迅速增加,如果事先知道对接方法能在多大程度上重现正确的配体结合模式并正确对其进行排序,这将非常有趣。显然,目前借助计算对接设计针对 M 的药物的尝试将受益于对接程序预测正确结合模式和正确评分的能力的先验知识。在当前的工作中,我们测试了几种领先的对接程序,即 Glide、DOCK、AutoDock、AutoDock Vina、FRED 和 EnzyDock,以正确识别和评分 193 个晶体结构中 M 配体的结合模式。在非共价结合配体的情况下(Glide:表现最好),没有一个代码能够正确识别超过 26%的晶体结构结合模式(最低能量构象,均方根偏差 < 2 Å),而对于共价结合配体,最高得分为 45%(EnzyDock)。这些结果表明,人们应该谨慎地进行 M 的计算机筛选,并且可能需要更全面的策略,包括配体自由能扰动,结合虚拟筛选和对接。

相似文献

1
Benchmarking the Ability of Common Docking Programs to Correctly Reproduce and Score Binding Modes in SARS-CoV-2 Protease Mpro.评估常见对接程序正确重现和评分 SARS-CoV-2 蛋白酶 Mpro 结合模式的能力。
J Chem Inf Model. 2021 Jun 28;61(6):2957-2966. doi: 10.1021/acs.jcim.1c00263. Epub 2021 May 28.
2
Compromise in Docking Power of Liganded Crystal Structures of M SARS-CoV-2 Surpasses 90% Success Rate.配体结合的 SARS-CoV-2 晶体结构对接的对接成功率超过 90%。
J Chem Inf Model. 2024 Mar 11;64(5):1628-1643. doi: 10.1021/acs.jcim.3c01552. Epub 2024 Feb 26.
3
Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease.结合不同对接引擎和共识策略,设计和验证 SARS-CoV-2 3CL 蛋白酶的优化虚拟筛选方案。
Molecules. 2021 Feb 4;26(4):797. doi: 10.3390/molecules26040797.
4
Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease.计算发现小分子类药物化合物作为潜在的 SARS-CoV-2 主蛋白酶抑制剂。
J Biomol Struct Dyn. 2021 Sep;39(15):5779-5791. doi: 10.1080/07391102.2020.1792989. Epub 2020 Jul 14.
5
In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.基于药物再利用的分子对接和动力学模拟预测 SARS-CoV-2 主要蛋白酶的潜在抑制剂的计算机预测。
J Infect Public Health. 2020 Sep;13(9):1210-1223. doi: 10.1016/j.jiph.2020.06.016. Epub 2020 Jun 16.
6
Optimization Rules for SARS-CoV-2 M Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site.SARS-CoV-2 M 抗病毒药物的优化规则:冠状病毒蛋白酶活性位点的整体对接和探索。
Viruses. 2020 Aug 26;12(9):942. doi: 10.3390/v12090942.
7
Protein-Ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2.使用 AutoDock4 进行蛋白-配体对接模拟聚焦于 SARS-CoV-2 的主要蛋白酶。
Curr Med Chem. 2021;28(37):7614-7633. doi: 10.2174/0929867328666210329094111.
8
Analysis of the Antidepressant Fluoxetine and Related Drugs at SARS-CoV-2 Main Protease (M) and Papain-like Protease (PL).分析抗抑郁药氟西汀和相关药物在 SARS-CoV-2 主蛋白酶(M)和木瓜蛋白酶样蛋白酶(PL)上的作用。
Curr Drug Discov Technol. 2023;20(2):e101022209771. doi: 10.2174/1570163819666221010115118.
9
Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.针对 SARS-CoV-2 主蛋白酶的潜在化合物的虚拟筛选、ADMET 预测和动力学模拟。
J Biomol Struct Dyn. 2021 Oct;39(17):6617-6632. doi: 10.1080/07391102.2020.1796812. Epub 2020 Jul 25.
10
Computational evaluation and benchmark study of 342 crystallographic holo-structures of SARS-CoV-2 Mpro enzyme.计算评估和 342 个 SARS-CoV-2 Mpro 酶晶体全息结构的基准研究。
Sci Rep. 2024 Jun 20;14(1):14255. doi: 10.1038/s41598-024-65228-5.

引用本文的文献

1
Enhancing PI3Kγ inhibitor discovery: a machine learning-based virtual screening approach integrating pharmacophores, docking, and molecular descriptors.增强PI3Kγ抑制剂的发现:一种基于机器学习的虚拟筛选方法,整合药效团、对接和分子描述符。
Mol Divers. 2025 May 13. doi: 10.1007/s11030-025-11216-4.
2
Moldina: a fast and accurate search algorithm for simultaneous docking of multiple ligands.Moldina:一种用于多个配体同时对接的快速且准确的搜索算法。
J Cheminform. 2025 Apr 28;17(1):61. doi: 10.1186/s13321-025-01005-4.
3
A Reflection on the Use of Molecular Simulation to Respond to SARS-CoV-2 Pandemic Threats.
关于利用分子模拟应对新冠疫情威胁的思考
J Phys Chem Lett. 2025 Apr 3;16(13):3249-3263. doi: 10.1021/acs.jpclett.4c03654. Epub 2025 Mar 21.
4
CHARMM-GUI for Protein-Ligand Docking of Multiple Reactive States along a Reaction Coordinate in Enzymes.用于酶中沿反应坐标的多个反应状态的蛋白质-配体对接的CHARMM-GUI
J Chem Theory Comput. 2025 Feb 25;21(4):2118-2128. doi: 10.1021/acs.jctc.4c01691. Epub 2025 Feb 14.
5
CHARMM at 45: Enhancements in Accessibility, Functionality, and Speed.CHARMM 45:可访问性、功能和速度的增强。
J Phys Chem B. 2024 Oct 17;128(41):9976-10042. doi: 10.1021/acs.jpcb.4c04100. Epub 2024 Sep 20.
6
In silico fragment-based discovery of CIB1-directed anti-tumor agents by FRASE-bot.基于 FRASE-bot 的基于片段的计算机虚拟筛选发现 CIB1 定向抗肿瘤剂。
Nat Commun. 2024 Jul 2;15(1):5564. doi: 10.1038/s41467-024-49892-9.
7
Advances, opportunities, and challenges in methods for interrogating the structure activity relationships of natural products.天然产物结构-活性关系研究方法的进展、机遇与挑战。
Nat Prod Rep. 2024 Oct 17;41(10):1543-1578. doi: 10.1039/d4np00009a.
8
Computational evaluation and benchmark study of 342 crystallographic holo-structures of SARS-CoV-2 Mpro enzyme.计算评估和 342 个 SARS-CoV-2 Mpro 酶晶体全息结构的基准研究。
Sci Rep. 2024 Jun 20;14(1):14255. doi: 10.1038/s41598-024-65228-5.
9
Alchemical approach performance in calculating the ligand-binding free energy.炼金术方法在计算配体结合自由能方面的性能。
RSC Adv. 2024 May 8;14(21):14875-14885. doi: 10.1039/d4ra00692e. eCollection 2024 May 2.
10
Considerations Around Structure-Based Drug Discovery for KRAS Using DOCK.考虑使用 DOCK 进行 KRAS 的基于结构的药物发现。
Methods Mol Biol. 2024;2797:67-90. doi: 10.1007/978-1-0716-3822-4_6.